1. Predictive markers for anti-EGFR antibodies in colorectal cancer: the beginning of a new era

   • Eric Van Cutsem
   • Sabine Tejpar

   Editorial 13 November 2008 Pages: 223 - 225

2. Functional inactivation of CD4+CD25^high regulatory T cells using low dose human/mouse chimeric anti-CD25 monoclonal antibody enhanced lymphokine-activated killer cells activity

   • Riki Okita
   • Yoshiyuki Yamaguchi
   • Kazuo Matsuura

   Original Research 11 November 2008 Pages: 227 - 234

   

3. Mechanisms of resistance to EGFR tyrosine kinase inhibitors: implications for patient selection and drug combination strategies

   • Alexandra Eyzaguirre
   • Elizabeth Buck
   • Mark R. Miglarese

   Review Open access 24 October 2008 Pages: 235 - 243

   

4. Management of skin toxicity of epidermal growth factor receptor inhibitors

   • Siegfried Segaert

   Day-to-Day Practice 08 October 2008 Pages: 245 - 251

   

5. Complete pathological response of colorectal liver metastases after chemotherapy and bevacizumab treatment: a case report

   • F. Vitiello
   • V. Ricci
   • F. Ciardiello

   Day-to-Day Practice 30 October 2008 Pages: 253 - 258

6. Successful treatment of brain metastases from renal cell cancer using radiotherapy in combination with sorafenib

   • Ulrika Stierner
   • Zahra Taheri-Kadkhoda

   Day-to-Day Practice 08 October 2008 Pages: 259 - 264

   

7. Plasma cell leukemia: advantages of treatment with bortezomib

   • N. Fraimout
   • B. Kadouch
   • N. Mounier

   Day-to-Day Practice 20 November 2008 Pages: 265 - 267